Attached files
EXHIBIT
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have
issued our report dated March 31, 2009, accompanying the consolidated financial
statements of Access Pharmaceuticals, Inc. as of and for the year ended December
31, 2008, included in the Annual Report on Form 10-K filed with the Securities
and Exchange Commission on March 31, 2009, which is included in this
Registration Statement. We consent to the inclusion in Amendment No. 3 to the
Registration Statement of Access Pharmaceuticals, Inc. on Form S-1 of the
aforementioned report. We also consent to the reference to our firm under the
heading "Experts" in such Registration Statement.
/s/ Whitley Penn
LLP
Dallas,
Texas
Janaury
20, 2010